Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data
Social Psychiatry and Psychiatric Epidemiology · 2023-10 · 58 (10) · 1503-1508
DOI: 10.1007/s00127-023-02448-6 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Social Psychiatry and Psychiatric Epidemiology, online erschienen am 06.03.2023. Verfasst von Nicholas L Bormann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Indiana University, 355 W 16th St.,, Indianapolis, IN, 46202, USA. nlborman@iu.edu. Hauptthemen laut MEDLINE: Hallucinogens, Substance-Related Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: SAMHSA HHS, HRSA HHS, Iowa Department of Public Health.
Abstract (Originalsprache)
PURPOSE: Psychedelics are being explored for their potential therapeutic benefits across a wide range of psychiatric diagnoses and may usher in a new age in psychiatric treatment. There is stigma associated with these currently illegal substances, and use varies by race and age. We hypothesized that minoritized racial and ethnic populations, relative to White respondents, would perceive psychedelic use as riskier. METHODS: Using 2019 cross-sectional data from the National Survey of Drug Use and Health, we conducted a secondary analysis of 41,679 respondents. Perceived risk of heroin was used as a surrogate for overall risk of illegal substance use; heroin and lysergic acid diethylamide were the only substances queried this way in the sample. RESULTS: A majority regarded lysergic acid diethylamide (66.7%) and heroin (87.3%) as a great risk if used once or twice. There were clear differences by race, with White respondents and those indicating more than one race having significantly lower perceived risk of lysergic acid diethylamide than respondents from other groups. Perceived risk of use also significantly increased with age. CONCLUSION: Perceived risk of lysergic acid diethylamide is unevenly distributed across the population. Stigma and racial disparities in drug-related crimes likely contribute to this. As research into potential therapeutic indications for psychedelics continues, perceived risk of use may change.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Indiana University, 355 W 16th St.,, Indianapolis, IN, 46202, USA. nlborman@iu.edu.
- Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
- Department of Internal Medicine, University of Iowa, Iowa City, IA, USA.
- Department of Pharmacy, University of Iowa, Iowa City, IA, USA.
- Department of Family Medicine, University of Iowa, Iowa City, IA, USA.
- Department of Biostatistics, University of Iowa, Iowa City, IA, USA.
Förderung
- SAMHSA HHS
- HRSA HHS
- Iowa Department of Public Health
- Substance Abuse and Mental Health Services Administration
- Health Resources and Services Administration
Zitieren
APA
Bormann, N. L., Weber, A. N., Miskle, B., Woodson-DeFauw, N., Arndt, S., & Lynch, A. C. (2023). Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data. Social Psychiatry and Psychiatric Epidemiology, 58(10), 1503-1508. https://doi.org/10.1007/s00127-023-02448-6
Vancouver
Bormann NL, Weber AN, Miskle B, Woodson-DeFauw N, Arndt S, Lynch AC. Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data. Social Psychiatry and Psychiatric Epidemiology. 2023;58(10):1503-1508. doi:10.1007/s00127-023-02448-6
BibTeX
@article{Bormann2023,
author = {Bormann, Nicholas L and Weber, Andrea N and Miskle, Benjamin and Woodson-DeFauw, Nicole and Arndt, Stephan and Lynch, Alison C},
title = {Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data},
journal = {Social Psychiatry and Psychiatric Epidemiology},
year = {2023},
volume = {58},
number = {10},
pages = {1503--1508},
doi = {10.1007/s00127-023-02448-6}
}
EUVIMED